Impact of a high-fat meal on assessment of clopidogrel-induced platelet inhibition in healthy subjects

Paul P. Dobesh, Jamela F. Urban, Scott W. Shurmur, Julie H. Oestreich

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Ideal conditions for platelet reactivity testing are critical for optimal selection of a P2Y12 inhibitor. Data are inconsistent regarding the impact of high-fat meals on test assessment. Methods: Participants included 12 healthy subjects not taking antiplatelet drugs after a 12-hour fast. After baseline assessment, subjects were given a 600 mg dose of clopidogrel. Four hours later, maximum platelet inhibition was tested in the fasting state by light transmission aggregometry (LTA), VerifyNow P2Y12, vasodilator-stimulated phosphoprotein (VASP), and whole blood aggregometry (WBA). Subjects were then provided a high-fat meal, and platelet function was evaluated two hours later. Change in measured platelet aggregation by LTA was the primary endpoint of the study. The Wilcoxon Rank Sum test was used to compare the change in platelet reactivity between fasting and non-fasting conditions. The Spearman rho (ρ) correlation coefficient was used to evaluate the association between fasting platelet reactivity and the change following a high-fat meal. Results: No significant change occurred in maximal light transmission, as assessed by LTA with 5 μM ADP (p = 0.15) and with 20 μM ADP (p = 0.07). There was a significant change in the area under the curve with 5 μM ADP (p=0.03) but not with 20 μM ADP (p = 0.18). Although there was no significant change with the VerifyNow P2Y12 assay (p = 0.16), the change was correlated with the initial fasting value (Spearman's rho p = 0.008). The VASP assay and WBA varied minimally. Conclusion: The high-fat meal did not significantly alter platelet function assessment of commonly used platelet function tests. Greater intra-subject variability existed for the optically-dependent compared with non-optically dependent tests.

Original languageEnglish (US)
Article number3
JournalThrombosis Journal
Volume13
Issue number1
DOIs
StatePublished - Jan 23 2015

Fingerprint

clopidogrel
Meals
Healthy Volunteers
Blood Platelets
Fats
Adenosine Diphosphate
Fasting
Light
Nonparametric Statistics
Platelet Function Tests
Platelet Aggregation Inhibitors
Platelet Aggregation
Area Under Curve
Inhibition (Psychology)

Keywords

  • Blood platelets
  • Clopidogrel
  • Diet
  • High-fat
  • P2Y12 purinoceptor antagonist
  • Platelet function tests

ASJC Scopus subject areas

  • Hematology

Cite this

Impact of a high-fat meal on assessment of clopidogrel-induced platelet inhibition in healthy subjects. / Dobesh, Paul P.; Urban, Jamela F.; Shurmur, Scott W.; Oestreich, Julie H.

In: Thrombosis Journal, Vol. 13, No. 1, 3, 23.01.2015.

Research output: Contribution to journalArticle

Dobesh, Paul P. ; Urban, Jamela F. ; Shurmur, Scott W. ; Oestreich, Julie H. / Impact of a high-fat meal on assessment of clopidogrel-induced platelet inhibition in healthy subjects. In: Thrombosis Journal. 2015 ; Vol. 13, No. 1.
@article{213bc74910cf47c6b54135f530fd10db,
title = "Impact of a high-fat meal on assessment of clopidogrel-induced platelet inhibition in healthy subjects",
abstract = "Background: Ideal conditions for platelet reactivity testing are critical for optimal selection of a P2Y12 inhibitor. Data are inconsistent regarding the impact of high-fat meals on test assessment. Methods: Participants included 12 healthy subjects not taking antiplatelet drugs after a 12-hour fast. After baseline assessment, subjects were given a 600 mg dose of clopidogrel. Four hours later, maximum platelet inhibition was tested in the fasting state by light transmission aggregometry (LTA), VerifyNow P2Y12, vasodilator-stimulated phosphoprotein (VASP), and whole blood aggregometry (WBA). Subjects were then provided a high-fat meal, and platelet function was evaluated two hours later. Change in measured platelet aggregation by LTA was the primary endpoint of the study. The Wilcoxon Rank Sum test was used to compare the change in platelet reactivity between fasting and non-fasting conditions. The Spearman rho (ρ) correlation coefficient was used to evaluate the association between fasting platelet reactivity and the change following a high-fat meal. Results: No significant change occurred in maximal light transmission, as assessed by LTA with 5 μM ADP (p = 0.15) and with 20 μM ADP (p = 0.07). There was a significant change in the area under the curve with 5 μM ADP (p=0.03) but not with 20 μM ADP (p = 0.18). Although there was no significant change with the VerifyNow P2Y12 assay (p = 0.16), the change was correlated with the initial fasting value (Spearman's rho p = 0.008). The VASP assay and WBA varied minimally. Conclusion: The high-fat meal did not significantly alter platelet function assessment of commonly used platelet function tests. Greater intra-subject variability existed for the optically-dependent compared with non-optically dependent tests.",
keywords = "Blood platelets, Clopidogrel, Diet, High-fat, P2Y12 purinoceptor antagonist, Platelet function tests",
author = "Dobesh, {Paul P.} and Urban, {Jamela F.} and Shurmur, {Scott W.} and Oestreich, {Julie H.}",
year = "2015",
month = "1",
day = "23",
doi = "10.1186/s12959-014-0033-x",
language = "English (US)",
volume = "13",
journal = "Thrombosis Journal",
issn = "1477-9560",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Impact of a high-fat meal on assessment of clopidogrel-induced platelet inhibition in healthy subjects

AU - Dobesh, Paul P.

AU - Urban, Jamela F.

AU - Shurmur, Scott W.

AU - Oestreich, Julie H.

PY - 2015/1/23

Y1 - 2015/1/23

N2 - Background: Ideal conditions for platelet reactivity testing are critical for optimal selection of a P2Y12 inhibitor. Data are inconsistent regarding the impact of high-fat meals on test assessment. Methods: Participants included 12 healthy subjects not taking antiplatelet drugs after a 12-hour fast. After baseline assessment, subjects were given a 600 mg dose of clopidogrel. Four hours later, maximum platelet inhibition was tested in the fasting state by light transmission aggregometry (LTA), VerifyNow P2Y12, vasodilator-stimulated phosphoprotein (VASP), and whole blood aggregometry (WBA). Subjects were then provided a high-fat meal, and platelet function was evaluated two hours later. Change in measured platelet aggregation by LTA was the primary endpoint of the study. The Wilcoxon Rank Sum test was used to compare the change in platelet reactivity between fasting and non-fasting conditions. The Spearman rho (ρ) correlation coefficient was used to evaluate the association between fasting platelet reactivity and the change following a high-fat meal. Results: No significant change occurred in maximal light transmission, as assessed by LTA with 5 μM ADP (p = 0.15) and with 20 μM ADP (p = 0.07). There was a significant change in the area under the curve with 5 μM ADP (p=0.03) but not with 20 μM ADP (p = 0.18). Although there was no significant change with the VerifyNow P2Y12 assay (p = 0.16), the change was correlated with the initial fasting value (Spearman's rho p = 0.008). The VASP assay and WBA varied minimally. Conclusion: The high-fat meal did not significantly alter platelet function assessment of commonly used platelet function tests. Greater intra-subject variability existed for the optically-dependent compared with non-optically dependent tests.

AB - Background: Ideal conditions for platelet reactivity testing are critical for optimal selection of a P2Y12 inhibitor. Data are inconsistent regarding the impact of high-fat meals on test assessment. Methods: Participants included 12 healthy subjects not taking antiplatelet drugs after a 12-hour fast. After baseline assessment, subjects were given a 600 mg dose of clopidogrel. Four hours later, maximum platelet inhibition was tested in the fasting state by light transmission aggregometry (LTA), VerifyNow P2Y12, vasodilator-stimulated phosphoprotein (VASP), and whole blood aggregometry (WBA). Subjects were then provided a high-fat meal, and platelet function was evaluated two hours later. Change in measured platelet aggregation by LTA was the primary endpoint of the study. The Wilcoxon Rank Sum test was used to compare the change in platelet reactivity between fasting and non-fasting conditions. The Spearman rho (ρ) correlation coefficient was used to evaluate the association between fasting platelet reactivity and the change following a high-fat meal. Results: No significant change occurred in maximal light transmission, as assessed by LTA with 5 μM ADP (p = 0.15) and with 20 μM ADP (p = 0.07). There was a significant change in the area under the curve with 5 μM ADP (p=0.03) but not with 20 μM ADP (p = 0.18). Although there was no significant change with the VerifyNow P2Y12 assay (p = 0.16), the change was correlated with the initial fasting value (Spearman's rho p = 0.008). The VASP assay and WBA varied minimally. Conclusion: The high-fat meal did not significantly alter platelet function assessment of commonly used platelet function tests. Greater intra-subject variability existed for the optically-dependent compared with non-optically dependent tests.

KW - Blood platelets

KW - Clopidogrel

KW - Diet

KW - High-fat

KW - P2Y12 purinoceptor antagonist

KW - Platelet function tests

UR - http://www.scopus.com/inward/record.url?scp=84924097346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924097346&partnerID=8YFLogxK

U2 - 10.1186/s12959-014-0033-x

DO - 10.1186/s12959-014-0033-x

M3 - Article

C2 - 25642145

AN - SCOPUS:84924097346

VL - 13

JO - Thrombosis Journal

JF - Thrombosis Journal

SN - 1477-9560

IS - 1

M1 - 3

ER -